BRIM BIOTECHNOLOGY
Founded in 2013, Quanfu Biotechnology Co., Ltd. (hereinafter referred to as Quanfu Biotech) is based in Taiwan and uses the core competitiveness of the translation science field to integrate the virtual team's operating model and is committed to the development of innovative drugs. โโThe professional team of Quanfu Biotech has screened the innovation sources of domestic and foreign companies with rich experience in new drug development, including: academic research, small biotechnology compa... nies, and international pharmaceutical companies, for joint research and development, technology introduction, etc. In a way that closely combines the energy of both parties to develop drug development, and then introduces the most suitable CRO and CMO strategic partners to promote innovative drugs to the โproof of conceptโ (POC) stage, followed by authorization and partnering. In this way, the research and development of innovative drugs will be handed over to the most potential development team, and the late clinical trials of drug research and development will be carried out to push the products to the market.
BRIM BIOTECHNOLOGY
Industry:
Biotechnology Pharmaceutical
Founded:
2013-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.brimbiotech.com
Status:
Active
Contact:
+886-2-2659-8586
Email Addresses:
[email protected]
Total Funding:
18 M USD
Technology used in webpage:
SPF Google Apps For Business Google Maps Microsoft Azure DNS
Similar Organizations
Amyndas Pharmaceuticals S.A.
Amyndas is a pharmaceutical company
CloudKrate
CloudKrate is a biotechnology and pharmaceutical company.
Galaxy Biotech
Galaxy Biotech is a pharmaceutical company.
Swift Biotechnology
Swift Biotechnology is a Phermaceutical Company.
SynCore Biotechnology
SynCore Biotechnology is a biopharmaceutical company
Current Employees Featured
Founder
Official Site Inspections
http://www.brimbiotech.com Semrush global rank: 5.52 M Semrush visits lastest month: 1.54 K
- Host name: wp3.g-dns.com
- IP address: 43.254.18.19
- Location: Taiwan
- Latitude: 23.5
- Longitude: 121
- Timezone: Asia/Taipei

More informations about "BRIM Biotechnology"
BRIM Biotechnology - BRIM Biotechnology, Inc.
Worldwide license for developing PDSP. In 2015, BRIM was granted an exclusive, worldwide license for developing PDSP in all therapeutic indications including dry eye disease, corneal wound healing, diabetic ulcer wound โฆSee details»
About us - BRIM Biotechnology, Inc.
BRIM Biotechnology applies integrated and efficient translational science to develop new treatments that help combat and cure disease. The company was founded in August 2013 in โฆSee details»
Corporate Governance - BRIM Biotechnology, Inc.
Andrew Lin is the Chairman of TaiRx, Inc. and Nuwa Healthcare. He also serves on the Independent Board of Directors for Fubon Insurance, and is the co-founder of Affinity โฆSee details»
BRIM Biotechnology, Inc. | LinkedIn
BRIM is a clinical-stage company developing novel peptide treatments for hard-to-treat diseases. BRIMโs first-in-class assets are based on its innovative stem cell regenerative PDSP technology ...See details»
BRIM Biotechnology - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +886-2-2659-8586 Founded in 2013, Quanfu Biotechnology Co., Ltd. (hereinafter referred to as Quanfu Biotech) is based in Taiwan โฆSee details»
BRIM Biotechnology, Inc. - Drug pipelines, Patents, Clinical
BRIM Biotechnology, Inc. Yi-Chun Maria Chen, PhD E: [email protected] T: 886 2 2659 8586 Sciad Communications, Media Relations Maria Patey / Sophie Protheroe E: โฆSee details»
BRIM Biotechnology Company Description - Stock Analysis
Dec 31, 2024 Company profile for BRIM Biotechnology, Inc. (TPE: 6885) with a description, list of executives, contact details and other key facts.See details»
BRIM Biotechnology - Products, Competitors, Financials, โฆ
Brimbiotech.com. Overview & Products; Financials; Founded Year 2013. Stage PIPE | IPO. Market Cap 4.93B. Stock Price 29.85. About BRIM Biotechnology. BRIM Biotechnology is a โฆSee details»
BRIM Biotechnology, Inc. | VentureRadar
Website: https://www.brimbiotech.com. Develops novel drugs for unmet medical needs, utilizing a virtual business model and strategic outsourcing to maintain low costs. 2017 BIO International โฆSee details»
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Development Milestones: Corporate Milestones: Leaders in Translational Science โข Our unique PDSP technology platform promotes the proliferation and differentiation of stem cellsSee details»
BRM-421 - Drug Targets, Indications, Patents - Synapse
Apr 10, 2025 Originator Organization. BRIM Biotechnology, Inc. Active Organization. Grand Pharmaceutical (China) Co., Ltd. BRIM Biotechnology, Inc. ... [email protected] T: 886 2 โฆSee details»
Corporate Governance - STAGING BRIM Biotechnology, Inc.
Discover our passionate team of entrepreneurial global biotechnology and pharma experts working to deliver on BRIMโs mission.See details»
BRIM Biotechnology strengthens leadership team in preparation โฆ
Feb 20, 2023 [e] [email protected]. Sciad Communications Ltd Maria Patey / Sophie Protheroe [t] 020 3405 7892 [e] [email protected]. Notes to Editors. About โฆSee details»
BRIM Biotechnology - Overview, News & Similar companies
May 10, 2023 Who is BRIM Biotechnology. BRIM Biotechnology, Inc. was established in July 2013 to accelerate the drug development process from candidate selection through to late โฆSee details»
BRIM Biotechnology, Inc. Overview | SignalHire Company Profile
Organization Website: brimbiotech.com : Phone Number +886-2-2659-8586: BRIM Biotechnology, ... industriesSee details»
Ascendo Biotechnology, Inc. (ๅ ็ฅ็็ฉ็งๆ่กไปฝๆ้ๅ ฌๅธ) - ่ฏ็ฉ็ฎก โฆ
For investment-related inquiries, please contact: [email protected] BRIM Biotechnology, Inc. Yi-Chun Maria Chen, PhD T: 886 2 2659 8586 #110 E: [email protected] Sciad โฆSee details»
BRIM Biotechnology | Business Model
Address: 8F, No.1, Alley 30, Lane 358, Ruiguang Rd.,Neihu Dist., Taipei 11492, Taiwan Tel: +886-2-2659-8586 Fax: +886-2-2659-8779 Email: [email protected]See details»
BRIM Biotechnology receives FDA agreement on Phase 3 clinical โฆ
Nov 1, 2022 E: [email protected]. Sciad Communications. Maria Patey / Sophie Protheroe T: 020 3405 7892 E: [email protected]. Notes to Editors. About BRIM โฆSee details»
BRIM Biotechnologyโs lead candidate BRM421 for Dry Eye ... - Sciad
Taipei, Taiwan, 29th June 2021 / Sciad Newswire / BRIM Biotechnology, Inc. (โBRIMโ) is pleased to advise that the Type C meeting with the US Food and Drug Administration (FDA) for the โฆSee details»
How the Biotechnology Industry Works | Umbrex
Biotechnology companies ultimately serve a variety of customers and end-users across multiple sectors. The major customer segments include: Healthcare Providers and Patients: For โฆSee details»